TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | -4 | -3 | -2 | -37 | -71 | -23 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/11 20:26 | 2/3/11 | ELTP | Elite Pharmaceuticals Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Whitnell Jeffrey A | NJ | D | P | 14 | 0.0400 | 0 | 341 | New | 341 | D | |||||||||||||||
11/14/07 17:25 | 11/12/07 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Whitnell Jeffrey A | IL | O | CFO | S.m | -107 | 6.93 | 2 | -15 | -16 | 83 | D | 77 | 59 | 7 | -4 | -8 | 1 | -2 | 1 | 0 | -4 | -3 | -2 | -37 | -71 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |